Skip to content

Qian Liu

6 papers in the library · 17 citations · publishing 2009-2026

Papers

Sort Most recent Most cited

Optimal doses of mind-body exercise on neuroinflammation in individuals with neuropsychiatric disorders: A systematic review and dose-response meta-analysis.

Brain, Behavior, & Immunity - Health March 1, 2026 Qingying Zheng, Guoyuan Huang, Qian Liu et al.

Mind-body exercises (MBEs), including Tai Chi (TC), Qigong (QG), Yoga (YG), and Mindfulness-Based Stress Reduction (MBSR), show promise in neuropsychiatric rehabilitation by modulating neuroinflammation. This study systematically examines the effects of MBEs on neuroinflammation-related biomarkers in neuropsychiatric disorders, aiming to identify optimal modalities, dosages, and key moderators....

DOI: 10.1016/j.bbih.2026.101176 (opens in new tab) Full text (opens in new tab) Inflammatory cytokines Mind-body therapies Neuroinflammation Neuropsychiatric disorders +1

ED95 of Ciprofol Combined with Esketamine or Sufentanil in Elderly Patients Undergoing Endoscopic Submucosal Dissection: A Dose-Finding and Randomized Controlled Trial

Drug Design, Development and Therapy February 1, 2026 Xiaoxue Qin, Hui Jiang, Yan Xie et al. 1 citation

Background: This study aimed to estimate the 95% effective dose (ED95) of ciprofol when combined with esketamine or sufentanil in elderly patients undergoing endoscopic submucosal dissection (ESD), and to explore the associated clinical and safety profiles of these sedation strategies. Methods: This study was conducted in two phases. In Phase 1, 44 patients aged 65– 80 years undergoing ESD were...

DOI: 10.2147/dddt.s595458 (opens in new tab) Ketamine Sufentanil Anesthesia Randomized controlled trial +7

Efficacy and safety of esketamine hydrochloride adjunct to sufentanil in non-surgical patients under mechanical ventilation in the ICU (SENSATION trial): protocol for a multicentre, single-blind, randomised controlled trial.

BMJ Open September 25, 2024 Yi Long, Donghuang Hong, Haibin Ni et al. 1 citation

Pain is common in patients receiving mechanical ventilation in the intensive care unit (ICU). Intravenous opioids are recommended as first-line therapy for pain management; however, opioids have adverse side effects. Based on low-quality evidence, low-dose ketamine is therefore recommended as an opioid adjunct to reduce opioid consumption. Esketamine is an alternative to ketamine with greater...

DOI: 10.1136/bmjopen-2024-084469 (opens in new tab) Full text (opens in new tab) Pain management Randomized controlled trial Critical care medicine Esketamine therapy +2

A Social Media-Based Mindfulness Psycho-Behavioral Intervention (MCARE) for Patients With Acute Coronary Syndrome: Randomized Controlled Trial.

Journal of Medical Internet Research February 20, 2024 Huijing Zou, Sek Ying Chair, Bilong Feng et al. 15 citations

Psychological distress is common among patients with acute coronary syndrome (ACS) and has considerable adverse impacts on disease progression and health outcomes. Mindfulness-based intervention is a promising complementary approach to address patients' psychological needs and promote holistic well-being. This study aims to examine the effects of a social media-based mindfulness...

DOI: 10.2196/48557 (opens in new tab) Full text (opens in new tab) Anxiety Depression Acute coronary syndrome Cardiac rehabilitation +5

A mindfulness-oriented psycho-behavioral intervention for patients with acute coronary syndrome: A pilot study.

Heart & Lung August 21, 2023 Huijing Zou, Sek Ying Chair, Dan Luo et al.

Background: People frequently experience physical and psychological challenges (e.g., depression and anxiety) and high risk of poor prognosis after an acute coronary event. Mindfulness-based intervention holds promise as an effective approach to promoting health and well-being. Objectives: To explore the feasibility, acceptability, and potential effects on psychological distress, cardiovascular...

Discriminative stimulus functions in rats of AM1346, a high-affinity CB1R selective anandamide analog.

Psychopharmacology April 2009 Torbjörn U C Järbe, Chen Li, Qian Liu et al.

To characterize in vivo the high-affinity CB(1) cannabinoid receptor (CB(1)R) selective anandamide analog AM1346 [alkoxyacid amide of N-eicosa-tetraenylamine] using drug discrimination. Substitution tests involved Delta(9)-tetrahydrocannabinol (Delta(9)-THC) and R-(+)-methanandamide (mAEA), a metabolically stable analog of anandamide (AEA), as well as the CB(1)R antagonist/inverse agonist...